Living Cell and Otsuka establishing a 50/50 JV, to be named Diatranz Otsuka Ltd. to DiabeCell worldwide, except in China

Living Cell Technologies Ltd.

Australia / Small-Cap Biopharma (<$1 billion)

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Otsuka Pharmaceutical Co. Ltd.

Japan / Private Biopharma

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced